Early-Life Exposure to Substance Abuse and Risk of Type 2 Diabetes in Adulthood

Current Diabetes Reports

Volumn 15, Issue 8, 2015, Pages

  Vaiserman, A M ^a  

^a INSTITUTE OF GERONTOLOGY   (Ukraine)

Author keywords

Developmental programming; Intrauterine growth restriction; Metabolic syndrome; Prenatal substance abuse; Type 2 diabetes

Indexed keywords

SOMATOMEDIN C;

ADIPOGENESIS; ADULTHOOD; ALCOHOL ABUSE; APOPTOSIS; BODY MASS; COCAINE DEPENDENCE; DISEASE ASSOCIATION; EARLY LIFE EXPOSURE; EPIGENETICS; GLUCOSE HOMEOSTASIS; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL SMOKING; METABOLIC HEALTH STATUS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRENATAL EXPOSURE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; ADDICTION; ADULT; ANIMAL; CHILD; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEMALE; MATERNAL EXPOSURE; PREGNANCY; YOUNG ADULT;

ADULT; ANIMALS; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MATERNAL EXPOSURE; METABOLIC SYNDROME X; OBESITY; PREGNANCY; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84935850135     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-015-0624-3     Document Type: Review

References (75)

1. Wilmot E, Idris I. Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis. 2014;5(6):234–44.
2. Vaag A, Brøns C, Gillberg L, Hansen NS, Hjort L, Arora GP, et al. Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes. Acta Obstet Gynecol Scand. 2014;93(11):1099–108.
3. Inadera H. Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals. Environ Health Prev Med. 2013;18(3):185–97.
4. Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol. 2007;165(8):849–57.
5. Narkowicz S, Płotka J, Polkowska Ż, Biziuk M, Namieśnik J. Prenatal exposure to substance of abuse: a worldwide problem. Environ Int. 2013;54:141–63.
6. Sithisarn T, Granger DT, Bada HS. Consequences of prenatal substance use. Int J Adolesc Med Health. 2012;24(2):105–12.
7. Behnke M, Smith VC, Committee on Substance Abuse, Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics. 2013;131(3):e1009–24. This review provides information on the short- and long-term effects of the most common drugs involved in prenatal exposure: alcohol, nicotine, cocaine, opiates, marijuana, and methamphetamine.
8. Somm E, Schwitzgebel VM, Vauthay DM, Aubert ML, Hüppi PS. Prenatal nicotine exposure and the programming of metabolic and cardiovascular disorders. Mol Cell Endocrinol. 2009;304:69–77.
9. Milnerowicz-Nabzdyk E, Bizoń A. Effect of cigarette smoking on vascular flows in pregnancies complicated by intrauterine growth restriction. Reprod Toxicol. 2014;50:27–35.
10. Cupul-Uicab LA, Skjaerven R, Haug K, Melve KK, Engel SM, Longnecker MP. In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa cohort. Environ Health Perspect. 2012;120:355–60. This study shows that exposure to nicotine in utero is associated with hypertension, obesity, and gestational diabetes mellitus in adult women.
11. Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci. 2010;116:364–74.
12. Freitas AL, Abreu-Villaça Y, Passos MC, Lisboa PC. Neonatal nicotine exposure causes insulin and leptin resistance and inhibits hypothalamic leptin signaling in adult rat offspring. J Endocrinol. 2010;206:55–63.
13. Lisboa PC, de Oliveira E, de Moura EG. Obesity and endocrine dysfunction programmed by maternal smoking in pregnancy and lactation. Front Physiol. 2012;3:437.
14. Holloway AC, Cuu DQ, Morrison KM, Gerstein HC, Tarnopolsky MA. Transgenerational effects of fetal and neonatal exposure to nicotine. Endocrine. 2007;31:254–9.
15. Rhee KE, Phelan S, McCaffery J. Early determinants of obesity: genetic, epigenetic, and in utero influences. Int J Pediatr. 2012;2012:9.
16. Alexander BT, Henry Dasinger J, Intapad S. Effect of low birth weight on women’s health. Clin Ther. 2014;36(12):1913–23.
17. Tanvig M. Offspring body size and metabolic profile—effects of lifestyle intervention in obese pregnant women. Dan Med J. 2014;61(7):B4893.
18. Von K, Toschke A, Koletzko B, Slikker W. Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol. 2002;156:954–61.
19. Wideroe M, Vik T, Jacobsen G, Bakketeig L. Does maternal smoking during pregnancy cause childhood overweight? Paediatr Perinat Epidemiol. 2003;17:171–9.
20. Jaddoe VW, de Ridder MA, van den Elzen AP, Hofman A, Uiterwaal CS, Witteman JC. Maternal smoking in pregnancy is associated with cholesterol development in the offspring: a 27-years follow-up study. Atherosclerosis. 2008;196:42–8.
21. Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond). 2008;32(2):201–10.
22. Power C, Jefferis BJ. Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol. 2002;31 Suppl 2:413–9.
23. Thomas C, Hypponen E, Power C. Prenatal exposures and glucose metabolism in adulthood: are effects mediated through birth weight and adiposity? Diabetes Care. 2007;30:918–24.
24. Power C, Atherton K, Thomas C. Maternal smoking in pregnancy, adult adiposity and other risk factors for cardiovascular disease. Atherosclerosis. 2010;211:643–8.
25. Chiolero A, Kaufman JS. Metabolic mediators of body-mass index and cardiovascular risk. Lancet. 2014;383(9934):2042.
26. Geerts CC, Bots ML, Grobbee DE, Uiterwaal CS. Parental smoking and vascular damage in young adult offspring: is early life exposure critical? The atherosclerosis risk in young adults study. Arterioscler Thromb Vasc Biol. 2008;28:2296–302.
27. Montgomery SM, Ekbom A. Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. Br Med J. 2002;324:26–7. The hypothesis that maternal smoking during pregnancy increases both the risk of early onset type 2 diabetes and non-diabetic obesity in offspring was tested.
28. Mattsson K, Källén K, Longnecker MP, Rignell-Hydbom A, Rylander L. Maternal smoking during pregnancy and daughters’ risk of gestational diabetes and obesity. Diabetologia. 2013;56(8):1689–95. This study provides direct evidence that women prenatally exposed to nicotine are at higher risk of developing gestational diabetes and obesity.
29. Harris HR, Willett WC, Michels KB. Parental smoking during pregnancy and risk of overweight and obesity in the daughter. Int J Obes (Lond). 2013;37(10):1356–63.
30. Lajous M, Tondeur L, Fagherazzi G, de Lauzon-Guillain B, Boutron-Ruaualt MC, Clavel-Chapelon F. Childhood and adult secondhand smoke and type 2 diabetes in women. Diabetes Care. 2013;36(9):2720–5.
31. Pietraszek A, Gregersen S, Hermansen K. Alcohol and type 2 diabetes. A review. Nutr Metab Cardiovasc Dis. 2010;20(5):366–75.
32. Weinberg J, Sliwowska JH, Lan N, Hellemans KG. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome. J Neuroendocrinol. 2008;20:470–88.
33. Dörrie N, Föcker M, Freunscht I, Hebebrand J. Fetal alcohol spectrum disorders. Eur Child Adolesc Psychiatry. 2014;23(10):863–75.
34. Pruett D, Waterman EH, Caughey AB. Fetal alcohol exposure: consequences, diagnosis, and treatment. Obstet Gynecol Surv. 2013;68(1):62–9.
35. Vaiserman AM. Long-term health consequences of early-life exposure to substance abuse: an epigenetic perspective. J DOHaD. 2013;4:269–79.
36. Breese CR, D’Costa A, Ingram RL, et al. Long-term suppression of insulin-like growth factor-1 in rats after in utero ethanol exposure: relationship to somatic growth. J Pharmacol Exp Ther. 1993;264 Suppl 1:448–56.
37. Schneider HJ, Friedrich N, Klotsche J, Schipf S, Nauck M, Völzke H, et al. Prediction of incident diabetes mellitus by baseline IGF1 levels. Eur J Endocrinol. 2011;164(2):223–9.
38. Pennington JS, Shuvaeva TI, Pennington SN. Maternal dietary ethanol consumption is associated with hypertriglyceridemia in adult rat offspring. Alcohol Clin Exp Res. 2002;26(6):848–55.
39. Minuk GY, Meyers AF, Legare DJ, Sadri P, Lautt WW. Fetal exposure to alcohol results in adult insulin resistance in the rat. Proc West Pharmacol Soc. 1998;41:39–40.
40. Elton CW, Pennington JS, Lynch SA, Carver FM, Pennington SN. Insulin resistance in adult rat offspring associated with maternal dietary fat and alcohol consumption. J Endocrinol. 2002;173(1):63–71.
41. Chen L, Nyomba BL. Effects of prenatal alcohol exposure on glucose tolerance in the rat offspring. Metabolism. 2003;52(4):454–62.
42. Chen L, Nyomba BL. Whole body insulin resistance in rat offspring of mothers consuming alcohol during pregnancy or lactation: comparing prenatal and postnatal exposure. J Appl Physiol (1985). 2004;96(1):167–72.
43. Yao XH, Grégoire Nyomba BL. Abnormal glucose homeostasis in adult female rat offspring after intrauterine ethanol exposure. Am J Physiol Regul Integr Comp Physiol. 2007;292(5):R1926–33.
44. Yao XH, Chen L, Nyomba BL. Adult rats prenatally exposed to ethanol have increased gluconeogenesis and impaired insulin response of hepatic gluconeogenic genes. J Appl Physiol. 2006;100(2):642–8.
45. Xia LP, Shen L, Kou H, Zhang BJ, Zhang L, Wu Y, et al. Prenatal ethanol exposure enhances the susceptibility to metabolic syndrome in offspring rats by HPA axis-associated neuroendocrine metabolic programming. Toxicol Lett. 2014;226(1):98–105. This study demonstrated that prenatal ethanol exposure induces increased susceptibility to adult metabolic syndrome in male rat offspring fed with high-fat diet.
46. Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev. 2013;34(1):84–129.
47. Shen L, Liu Z, Gong J, Zhang L, Wang L, Magdalou J, et al. Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats. Toxicol Appl Pharmacol. 2014;274(2):263–73.
48. Harper KM, Tunc-Ozcan E, Graf EN, Redei EE. Intergenerational effects of prenatal ethanol on glucose tolerance and insulin response. Physiol Genomics. 2014;46(5):159–68.
49. Dobson CC, Mongillo DL, Brien DC, Stepita R, Poklewska-Koziell M, Winterborn A, et al. Chronic prenatal ethanol exposure increases adiposity and disrupts pancreatic morphology in adult guinea pig offspring. Nutr Diabetes. 2012;2:e57.
50. Dobson CC, Thevasundaram K, Mongillo DL, Winterborn A, Holloway AC, Brien JF, et al. Chronic prenatal ethanol exposure alters expression of central and peripheral insulin signaling molecules in adult guinea pig offspring. Alcohol. 2014;48(7):687–93.
51. Bauldry S, Shanahan MJ, Boardman JD, Miech RA, Macmillan R. A life course model of self-rated health through adolescence and young adulthood. Soc Sci Med. 2012;75(7):1311–20.
52. SAMHSA (Substance Abuse and Mental Health Services Administration). Results from the 2010 national survey on drug use and health: summary of national findings. Office of Applied Studies, NSDUH Series H-41, Rockville, Md, USA, 2011.
53. Plessinger MA, Woods Jr JR. Cocaine in pregnancy. Recent data on maternal and fetal risks. Obstet Gynecol Clin N Am. 1998;25(1):99–118.
54. Cressman AM, Natekar A, Kim E, Koren G, Bozzo P. Cocaine abuse during pregnancy. J Obstet Gynaecol Can. 2014;36(7):628–31.
55. Lipshultz SE, Frassica JJ, Orav J. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr. 1991;118:44–51.
56. Messiah SE, Lipshultz SE, Miller TL, Accornero VH, Bandstra ES. Assessing latent effects of prenatal cocaine exposure on growth and risk of cardiometabolic disease in late adolescence: design and methods. Int J Pediatr. 2012;2012:467918.
57. Messiah SE, Miller TL, Lipshultz SE, Bandstra ES. Potential latent effects of prenatal cocaine exposure on growth and the risk of cardiovascular and metabolic disease in childhood. Prog Pediatr Cardiol. 2011;31(1):59–65.
58. Shankaran S, Bann CM, Bauer CR, Lester BM, Bada HS, Das A, et al. Prenatal cocaine exposure and BMI and blood pressure at 9 years of age. J Hypertens. 2010;28(6):1166–75.
59. LaGasse LL, Gaskins RB, Bada HS, Shankaran S, Liu J, Lester BM, et al. Prenatal cocaine exposure and childhood obesity at nine years. Neurotoxicol Teratol. 2011;33(2):188–97.
60. Ganapathy V, Prasad PD, Ganapathy ME, Leibach FH. Drugs of abuse and placental transport. Adv Drug Deliv Rev. 1999;38(1):99–110.
61. Suzuki K, Minei LJ, Johnson EE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol. 1980;136(8):1009–13.
62. Aliyu MH, Wilson RE, Zoorob R, Brown K, Alio AP, Clayton H, et al. Prenatal alcohol consumption and fetal growth restriction: potentiation effect by concomitant smoking. Nicotine Tob Res. 2009;11(1):36–43.
63. Hayatbakhsh MR, Flenady VJ, Gibbons KS, Kingsbury AM, Hurrion E, Mamun AA, et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012;71(2):215–9.
64. Liu AJ, Sithamparanathan S, Jones MP, Cook CM, Nanan R. Growth restriction in pregnancies of opioid-dependent mothers. Arch Dis Child Fetal Neonatal Ed. 2010;95(4):F258–62.
65. Huber G, Seelbach-Göbel B. Substance abuse and pregnancy from an obstetric point of view. Z Geburtshilfe Neonatol. 2014;218(4):142–8.
66. Ross LJ, Wilson M, Banks M, Rezannah F, Daglish M. Prevalence of malnutrition and nutritional risk factors in patients undergoing alcohol and drug treatment. Nutrition. 2012;28(7-8):738–43.
67. Santolaria F, Gonzalez-Reimers E. Alcohol and nutrition: an integrated perspective. In: Watson RR, Preedy VR, editors. Nutrition and alcohol: linking nutrient interactions and dietary intake. Boca Raton: CRC Press; 2004. p. 3–17.
68. Zoli M, Picciotto MR. Nicotinic regulation of energy homeostasis. Nicotine Tob Res. 2012;14(11):1270–90.
69. Ersche KD, Stochl J, Woodward JM, Fletcher PC. The skinny on cocaine: insights into eating behavior and body weight in cocaine-dependent men. Appetite. 2013;71:75–80.
70. Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012;345:e4439.
71. Sofuoglu M, Dudish-Poulsen S, Poling J, Mooney M, Hatsukami DK. The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users. Addict Behav. 2005;30(6):1125–34.
72. Cocores JA, Gold MS. The Salted Food Addiction Hypothesis may explain overeating and the obesity epidemic. Med Hypotheses. 2009;73(6):892–9.
73. Vik T, Jacobsen G, Vatten L, Bakketeig LS. Pre- and post-natal growth in children of women who smoked in pregnancy. Early Hum Dev. 1996;45:245–55.
74. Ross MG, Desai M. Developmental programming of offspring obesity, adipogenesis, and appetite. Clin Obstet Gynecol. 2013;56(3):529–36.
75. Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev. 2014;94(4):1027–76.